Clicky

Pfizer, Inc.(PFE) News

Date Title
May 28 With 67% ownership of the shares, Pfizer Inc. (NYSE:PFE) is heavily dominated by institutional owners
May 27 Is Pfizer Stock a Buy After This $1.25 Billion Investment?
May 27 Pfizer headquarters conversion project in Manhattan gets $720m loan
May 26 Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer
May 24 Junkiest Junk Is Offering a Warning Sign for Debt
May 24 Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost
May 24 Down 63%, Should You Buy the Dip on Pfizer?
May 24 Charting the Global Economy: Long-Term Bond Yields Soar Around the World
May 24 1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
May 24 U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
May 23 Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication
May 23 Pfizer (NYSE:PFE) Showcases New Cancer Treatment Study And Reports Prostate Cancer Drug Success
May 23 Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
May 23 Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial
May 22 Was Jim Cramer Right About Pfizer Inc. (PFE)?
May 22 Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
May 22 MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot
May 22 5 Low Price-to-Sales Stocks That Can Deliver Big Returns in 2025
Apr 28 Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs
Apr 28 4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold